Seagen
SGEN
#562
Rank
NZ$78.64 B
Marketcap
NZ$416.86
Share price
-0.07%
Change (1 day)
72.84%
Change (1 year)

Earnings for Seagen (SGEN)

Earnings in 2023 (TTM): -NZ$1.29 Billion

According to Seagen 's latest financial reports the company's current earnings are NZ$2.30 Billion. In 2022 the company made an earning of -NZ$1.12 Billion, an increase over its 2021 earnings that were of -NZ$1.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seagen from 2001 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -NZ$1.29 Billion14.85%
2022 -NZ$1.12 Billion-10.13%
2021 -NZ$1.25 Billion-214.28%
2020 NZ$1.08 B-370.63%
2019 -NZ$0.41 Billion-15.17%
2018 -NZ$0.48 Billion32.79%
2017 -NZ$0.36 Billion37.19%
2016 -NZ$0.27 Billion18%
2015 -NZ$0.23 Billion56.34%
2014 -NZ$0.15 Billion23.07%
2013 -NZ$0.12 Billion
2011 -NZ$0.27 Billion111.72%
2010 -NZ$0.13 Billion-19.63%
2009 -NZ$0.16 Billion-7.55%
2008 -NZ$0.17 Billion64.95%
2007 -NZ$0.11 Billion38.4%
2006 -NZ$73.27 Million25.36%
2005 -NZ$58.45 Million-14.86%
2004 -NZ$68.65 Million61.92%
2003 -NZ$42.4 Million-7.67%
2002 -NZ$45.92 Million6.76%
2001 -NZ$43.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$12.69 B-981.38%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$23.35 B-1,720.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$0.81 B-156.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$20.65 B-1,533.39%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$13.03 B-1,004.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-NZ$0.12 Billion-92.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
-NZ$0.12 Billion-92.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.6 Billion-58.79%๐Ÿ‡บ๐Ÿ‡ธ USA